Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?
The causative agent of the COVID-19 pandemic is undergoing several changes, and the evolutionary cascade of SARS-CoV-2 has led to the emergence of a range of variants of SARS-CoV-2. Additionally, the emergence of recombinant variants or super variants such as XBB.1.5, XBB.1.16, XBB.1.9.1, and XBB.1....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | Health Sciences Review |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772632023000533 |